Company Profile
Jaguar Health Stock Price, News & Analysis
- Ticker:
- JAGX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.00 USD (+3.80%)
Close
Last updated: July 27, 2026
2.12M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, JAGX closed up 3.80% at $0.9999. No new same-company headline was identified in the current news window.
Company overview
Business overview
Jaguar Health is a biopharmaceutical company focused on gastrointestinal and rare-disease therapies, with Mytesi as a key commercial asset. Its story combines niche commercialization with a pipeline aimed at high-unmet-need GI indications.
Geographic Base and Sector Classification
Jaguar Health is headquartered in the United States and listed on NASDAQ. It sits in specialty biopharma with a GI and rare-disease profile.
Business Model Characteristics
The business depends on product sales, label or indication expansion, and the ability to keep a narrow franchise financed. Investors usually watch commercial traction, regulatory progress, and pipeline updates.
Position Within the Biotechnology Landscape
Jaguar occupies a niche GI-specialty position within biotech. Its stock tends to move on commercial execution and the market's view of whether the portfolio can expand beyond a single product.
Future catalysts
The next few months for Jaguar Health are centered on its latest development priorities. The latest company update points to commercial rights for Mytesi ® and Canalevia ® -CA1 Company continues its focus on crofelemer development efforts for rare-disease intestinal failure indications. If that progress holds, the program should stay on the radar through the rest of the quarter. The partnership angle also matters here, especially around Q4 2025, buoyed by license of U.S.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
ABEO · Source: Abeona Therapeutics
- 02
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ABEO · Source: Abeona Therapeutics
- 03
- 04
Jaguar Health Compliant with Nasdaq Bid Price Rule
Source: Jaguar Health
- 05
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
ABEO · Source: Abeona Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Jaguar Health (JAGX)?
Jaguar Health (JAGX) most recently closed at 1.00 USD, a +3.80% move versus the previous session.
What is the market cap of Jaguar Health (JAGX)?
Jaguar Health currently has a market capitalization of 2.12M USD on BioPharmSignal.
What does Jaguar Health do?
Jaguar Health is a biopharmaceutical company focused on gastrointestinal and rare-disease therapies, with Mytesi as a key commercial asset. Its story combines niche commercialization with a pipeline aimed at high-unmet-need GI indications.
On which exchange is JAGX stock listed?
Jaguar Health (JAGX) is associated with NASDAQ, United States, Biopharma.
What is Jaguar?
The next few months for Jaguar Health are centered on its latest development priorities.
Which conditions is Jaguar Health targeting with Jaguar?
The next few months for Jaguar Health are centered on its latest development priorities.
How does Jaguar Health describe recent progress with Jaguar?
The next few months for Jaguar Health are centered on its latest development priorities.
What is Health?
Jaguar Health is a biopharmaceutical company focused on gastrointestinal and rare-disease therapies, with Mytesi as a key commercial asset.